{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:29:14Z","timestamp":1793042954598,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.amjsurg.2025.116706","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:33:38Z","timestamp":1761788018000},"page":"116706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Defining cure in patients with normocalcemic primary hyperparathyroidism: Should calcium or PTH be used?"],"prefix":"10.1016","volume":"253","author":[{"given":"Niranjna","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Caretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenessa","family":"Lindeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2923-6079","authenticated-orcid":false,"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2025.116706_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2024.115812","article-title":"Normocalcemic primary hyperparathyroidism: from pathophysiology to clinical management","volume":"235","author":"Wu","year":"2024","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116706_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism","volume":"26","author":"Sho","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2025.116706_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116706_bib4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s13304-021-01108-1","article-title":"How should we define cure after parathyroidectomy for normocalcemic primary hyperparathyroidism? A retrospective cohort study","volume":"73","author":"Cano-Valderrama","year":"2021","journal-title":"Update Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2025.116706_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00423-019-01782-1","article-title":"Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate","volume":"404","author":"Tr\u00e9bouet","year":"2019","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116706_bib6","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-20-0634","article-title":"Normocalcemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium","volume":"184","author":"Schini","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.amjsurg.2025.116706_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","article-title":"Surgical management of normocalcemic primary hyperparathyroidism","volume":"36","author":"Wade","year":"2012","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2025.116706_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.surg.2012.07.005","article-title":"Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?","volume":"152","author":"Carsello","year":"2012","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.amjsurg.2025.116706_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/SLA.0b013e31819a6ded","article-title":"What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?","volume":"249","author":"Ning","year":"2009","journal-title":"Ann Surg"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296102500529X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296102500529X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:38:57Z","timestamp":1781455137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296102500529X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":9,"alternative-id":["S000296102500529X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116706","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining cure in patients with normocalcemic primary hyperparathyroidism: Should calcium or PTH be used?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116706"}}